Please login to the form below

Not currently logged in
Email:
Password:

IMI appoints new chair of scientific committee

Portugal’s Maria Beatriz da Silva Lima to join EC’s collaborative research group

IMI Maria Beatriz da Silva LimaProf Maria Beatriz da Silva Lima has been elected chair of the Scientific Committee of the Innovative Medicines Initiative (IMI).

Prof da Silva Lima (pictured) of the University of Lisbon in Portugal will lead a 12-strogn committee, which provides strategic scientific advice to the IMI – a public-private partnership between the EC and the industry to improve health innovation in Europe.

The IMI also announced that Prof Markus Perola of Finland's National Institute for Health and Welfare as vice-chair of the Committee.

IMI executive director Michel Goldman said: 'The Scientific Committee represents the voice of the scientific community within IMI, and their input is vital to our success.

“I am looking forward to working with Maria Beatriz da Silva Lima and Markus Perola, and the rest of the committee, to foster open collaboration in pharmaceutical research.'

Prof da Silva Lima described the appointment as a “great honour” and praised the work of the IMI so far, which includes a dementia trials alliance between pharma companies and a research collaboration to discover new antibiotics.

She said: “Thanks to IMI, we have seen an enormous reformulation of the European research environment as well as researchers attitude. This re-thinking of the full drug development process is the most challenging and exciting exercise that I have experienced during my entire working life.

“Finally, there is huge potential to expand the principles underlying IMI to the rest of the world.”

16th January 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics